The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Arnason, Barry G.
overview Dr. Barry Arnason is an expert in the diagnosis and treatment of multiple sclerosis, autoimmune neuropathies, and myasthenia gravis. His clinical interests also include facial nerve problems, Guillain-Barre syndrome, trigeminal neuralgia, and Bell's palsy. Dr. Arnason sees several thousand patients per year--many are national and international referrals. Dr. Arnason's research focuses on immune cell function in multiple sclerosis. His laboratory is looking at the role of certain immune cells, including T suppressor cells, IFN-secreting cells, and NK cells. He is also exploring the protective effect of pregnancy in multiple sclerosis. Dr. Arnason shares with Dr. Ewa Chelmicka-Schorr an interest in nervous system immune system interaction. In addition, Dr. Arnason is overseeing clinical trials of several medications for multiple sclerosis: beta-interferon, retinoic acid, and copaxone
One or more keywords matched the following items that are connected to Arnason, Barry G.
Item TypeName
Concept Interferons
Concept Interferon-gamma
Concept Interferon-alpha
Concept Interferon-beta
Academic Article Interferon beta in multiple sclerosis.
Academic Article Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference.
Academic Article Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats.
Academic Article Role of interferons in demyelinating diseases.
Academic Article Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
Academic Article Mechanisms of action of interferon-beta in multiple sclerosis.
Academic Article Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.
Academic Article Interferon beta in multiple sclerosis.
Academic Article Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b.
Academic Article Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis.
Academic Article Immunologic therapy of multiple sclerosis.
Academic Article All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.
Academic Article Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis.
Academic Article Multiple sclerosis: additional thoughts.
Academic Article Interferons in relapsing remitting multiple sclerosis.
Academic Article Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Academic Article Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Academic Article Variability in detection and quantification of interferon ?-1b-induced neutralizing antibodies.
Academic Article Interferon ?-1b and glatiramer acetate effects on permanent black hole evolution.
Academic Article Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.
Academic Article Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Academic Article Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.
Academic Article 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
Academic Article Treatment of multiple sclerosis with interferon beta.
Academic Article Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Academic Article Correlation of the appearance of anti-interferon antibodies during treatment and dimunition of efficacy: summary of an International Workshop on Anti-Interferon Antibodies.
Academic Article MS Forum/MS Over the Past 17 Years.
Academic Article Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Academic Article Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study.
Academic Article Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Academic Article Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Academic Article Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Academic Article Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Academic Article Interferon-? corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
Concept Interferon beta-1a
Concept Interferon beta-1b
Search Criteria
  • Interferons